Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shulman

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Annals of Internal Medicine|February 1, 1988
Drug purpura due to surreptitious quinidine intakeD M Reid, N R Shulman
Food and Drug Law Journal|January 1, 1995
The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?S R Shulman, J S Brown
Pharmacoeconomics|January 8, 1996
The Prescription Drug User Fee Act of 1992. A 5-year experiment for industry and the FDAS R Shulman, K I Kaitin
Transfusion Medicine Reviews|October 1, 1993
Mechanisms of drug-induced immunologically mediated cytopeniasN R Shulman, D M Reid
Schweizerische Medizinische Wochenschrift|October 15, 1977
[ABO compatibility and isoimmune neonatal thrombopenia]A A Gratwohl, N R Shulman
Blood|August 1, 1970
Platelet cold agglutininsS P Watkins, N R Shulman
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1978
Catechol-O-methyl transferase activity in patients with depressive illness and anxiety statesR Shulman, J Griffiths, P Diewold
Blood|November 1, 1977
Megakaryocyte maturation indicated by methanol inhibition of an acid phosphatase shared by magakaryocytes and plateletsO S Markovic, N R Shulman
Biochemical and Biophysical Research Communications|October 9, 1970
Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMPS M Wolfe, N R Shulman
Psychological Medicine|November 1, 1989
Biopsychosocial aspects of long-term survival on end-stage renal failure therapyR Shulman, J D Price, J Spinelli
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Annals of Internal Medicine|February 1, 1988
Drug purpura due to surreptitious quinidine intakeD M Reid, N R Shulman
Food and Drug Law Journal|January 1, 1995
The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?S R Shulman, J S Brown
Pharmacoeconomics|January 8, 1996
The Prescription Drug User Fee Act of 1992. A 5-year experiment for industry and the FDAS R Shulman, K I Kaitin
Transfusion Medicine Reviews|October 1, 1993
Mechanisms of drug-induced immunologically mediated cytopeniasN R Shulman, D M Reid
Schweizerische Medizinische Wochenschrift|October 15, 1977
[ABO compatibility and isoimmune neonatal thrombopenia]A A Gratwohl, N R Shulman
Blood|August 1, 1970
Platelet cold agglutininsS P Watkins, N R Shulman
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1978
Catechol-O-methyl transferase activity in patients with depressive illness and anxiety statesR Shulman, J Griffiths, P Diewold
Blood|November 1, 1977
Megakaryocyte maturation indicated by methanol inhibition of an acid phosphatase shared by magakaryocytes and plateletsO S Markovic, N R Shulman
Biochemical and Biophysical Research Communications|October 9, 1970
Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMPS M Wolfe, N R Shulman
Psychological Medicine|November 1, 1989
Biopsychosocial aspects of long-term survival on end-stage renal failure therapyR Shulman, J D Price, J Spinelli
Pageof 12